You are here:

Schering-Plough Ltd

Name SMC ID No Status Sub. Type
 
buprenorphine/naloxone (Suboxone) 355/07 Restricted Full submission
etonogestrel (Nuvaring) 502/08 Accepted Resubmission
etonogestrel/ethinyl estradiol vaginal ring (NuvaRing) 502/08 Not Recommended Full submission
infliximab (Remicade) 374/07 Not Recommended Full submission
infliximab (Remicade) 374/07 Not Recommended Non submission
infliximab (Remicade) 101/04 Superseded Full submission
infliximab (Remicade) 448/08 Superseded Full submission
infliximab 100mg powder for intravenous infusion (Remicade) 363/07 Superseded Full submission
infliximab 100mg powder for intravenous infusion (Remicade) 318/06 Restricted Full submission
infliximab 100mg powder for intravenous infusion (Remicade) 364/07 Superseded Full submission
Interferon-alpha-2b/ Ribavarin (Viraferon/ Rebetol) 258/06 Accepted Full submission
Mometasone furoate (Asmanex Twisthaler®) 79/03 Restricted Full submission
pegylated interferon alfa 2b plus ribavirin (ViraferonPeg plus Rebetol) 488/08 Superseded Full submission
Pegylated interferon alfa-2b (ViraferonPeg®) 02/02 Restricted Full submission
pegylated liposomal doxorubicin (Caelyx) 503/08 Not Recommended Full submission
Pegylated liposomal doxorubicin (Caelyx®) 84/03 Not Recommended Full submission
pegylated liposomal doxorubicin in combination with boretezomib (Caelyx plus Velcade) 503/08 Not Recommended Resubmission
Posaconazole 40mg/ml Oral Suspension (Noxafil) 256/06 Accepted Full submission
posaconazole 40mg/ml oral suspension (Noxafil) 379/07 Restricted Full submission
temozolomide 5, 20, 100 and 250mg capsules (Temodal) 244/06 Restricted Resubmission
Temozolomide 5, 20, 100 and 250mg capsules (Temodal®) 244/06 Not Recommended Full submission

Back